Luxembourg vs Oman: Previously treated cases tested for RR-/MDR-TB
Luxembourg
100.0%
in 2024
Oman
100.0%
in 2024
Luxembourg rank
1st
Oman rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Luxembourg
- Oman
How they compare
Luxembourg currently reports 100.0% against 100.0% in Oman, a difference of 0.0%.
Across all 6 years both countries report, Oman has been ahead every year.
Luxembourg ranks 1st and Oman ranks 1st of 180 countries.
Oman has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Luxembourg | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100.0% | 100.0% | 0.0% | — |
| 2020s | 93.8% | 100.0% | 6.2% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Luxembourg or Oman?
- Luxembourg, at 100.0% against 100.0% in Oman as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Luxembourg and Oman?
- 0.0%, with Luxembourg ahead.
- How many years of comparable data are there for Luxembourg and Oman?
- 6 years are reported by both, from 2011 to 2024.
- How do Luxembourg and Oman rank globally for previously treated cases tested for rr-/mdr-tb?
- Luxembourg ranks 1st and Oman ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.